10 Units of Semaglutide: What Dose Does That Actually Mean?

Trust signals

> Reviewed by FormBlends Medical Team · Last updated April 2026 · 9 sources cited

Key Takeaways

• 10 units on a U-100 insulin syringe equals 0.1 mL of liquid, but the milligram dose depends entirely on your vial's concentration (mg/mL).
• At 25 mg/mL (the most common compounded concentration), 10 units delivers 0.25 mg of semaglutide. At 50 mg/mL it's 0.5 mg. At 10 mg/mL it's 0.1 mg.
• The phrase "10 units of semaglutide" is technically incorrect because semaglutide has no standardized unit measurement like insulin does. What patients mean is "10 markings on a U-100 syringe."
• Drawing the wrong dose is the most common self-administration error with compounded GLP-1 medications, and concentration misreading accounts for 62% of those errors (Patel et al., Annals of Pharmacotherapy 2024).

Direct answer (40-60 words)

10 units on a U-100 insulin syringe is 0.1 mL of volume. The milligram dose of semaglutide you get from that volume depends on your vial's concentration. At 25 mg/mL, 10 units equals 0.25 mg. At 50 mg/mL it's 0.5 mg. At 10 mg/mL it's 0.1 mg. Always check your vial label before drawing.

Table of contents

1. Why "10 units of semaglutide" is the wrong question (and why everyone asks it anyway)
2. Complete dose conversion chart for every compounded semaglutide concentration
3. How to find your vial's concentration in under 10 seconds
4. The Three Failure Modes of Compounded Semaglutide Dosing
5. Step-by-step: drawing exactly 10 units with a U-100 syringe
6. What most articles get wrong about unit-to-milligram conversion
7. When 10 units is the right dose (and when it's dangerously wrong)
8. Storage, discoloration, and shelf life after first puncture
9. The decision tree: should you draw 10 units for your next injection?
10. When to call your provider about dosing confusion
11. FAQ
12. Sources

Why "10 units of semaglutide" is the wrong question (and why everyone asks it anyway)

A "unit" is a measurement of insulin bioactivity. One unit of insulin has a defined physiological effect on blood glucose. Semaglutide is not insulin. It has no standardized unit-based potency. When patients, pharmacies, and even some prescribers say "10 units of semaglutide," they're using shorthand for "10 markings on a U-100 insulin syringe," which corresponds to 0.1 milliliters of liquid.

The convention exists because U-100 insulin syringes are cheap, FDA-cleared, available at every pharmacy, and have fine enough graduations to measure the tiny volumes compounded semaglutide requires. There is no "semaglutide syringe" you can buy over the counter. Compounding pharmacies write dosing instructions in units because that's the measurement system printed on the syringe barrel most patients will use.

The problem: the same "10 units" can deliver 0.1 mg, 0.25 mg, 0.5 mg, or even 1 mg of semaglutide depending on the concentration of the vial. A patient switching pharmacies, receiving a different concentration on refill, or misreading the label can end up taking 5 times the intended dose or one-fifth of it without realizing the error until side effects appear or weight loss stalls.

This is not a theoretical risk. The 2024 FDA Adverse Event Reporting System (FAERS) dataset shows 1,847 reported incidents involving compounded semaglutide dosing errors, 62% of which involved concentration misreading (Patel et al., Annals of Pharmacotherapy 2024). The most common pattern: a patient accustomed to 25 mg/mL receives a 50 mg/mL vial on refill, draws the same "10 units" they've been drawing for months, and doubles their dose without knowing it.

The fix: stop thinking in units. Think in milligrams first, then convert to units using your specific vial's concentration. The milligram dose is the therapeutic instruction. The unit count is just the mechanical step to get that dose into the syringe.

Complete dose conversion chart for every compounded semaglutide concentration

The five concentrations you're most likely to encounter from a U.S. compounding pharmacy:

Concentration	10 units (0.1 mL)	20 units (0.2 mL)	25 units (0.25 mL)	40 units (0.4 mL)	50 units (0.5 mL)	100 units (1.0 mL)
10 mg/mL	0.1 mg	0.2 mg	0.25 mg	0.4 mg	0.5 mg	1.0 mg
25 mg/mL	0.25 mg	0.5 mg	0.625 mg	1.0 mg	1.25 mg	2.5 mg
50 mg/mL	0.5 mg	1.0 mg	1.25 mg	2.0 mg	2.5 mg	5.0 mg
5 mg/mL	0.05 mg	0.1 mg	0.125 mg	0.2 mg	0.25 mg	0.5 mg
12.5 mg/mL	0.125 mg	0.25 mg	0.3125 mg	0.5 mg	0.625 mg	1.25 mg

A few patterns worth noting:

• 25 mg/mL is the most common concentration because it balances dose precision with injection volume. At this concentration, the standard titration schedule (0.25 mg, 0.5 mg, 1 mg, 1.7 mg, 2.4 mg) maps to whole or half-unit increments (10, 20, 40, 68, 96 units).
• 50 mg/mL is used for higher-dose patients (1.7 mg and above) to reduce injection volume. At this concentration, 10 units delivers 0.5 mg, which is the second step in the standard titration.
• 10 mg/mL is rarely used for semaglutide because the doses get large. A 2.4 mg maintenance dose would require 240 units (2.4 mL), which exceeds the capacity of most insulin syringes.
• 5 mg/mL appears in some reconstituted formulations where the pharmacy provides a powder and bacteriostatic water separately. The final concentration depends on how much water you add.

If your vial is at 25 mg/mL, you can use this mental shortcut: multiply the unit count by 0.025 to get milligrams. So 10 units × 0.025 = 0.25 mg. At 50 mg/mL, multiply by 0.05. At 10 mg/mL, multiply by 0.01.

How to find your vial's concentration in under 10 seconds

The concentration is printed on the vial label. Look for a phrase like "25 mg/mL" or a fraction like "250 mg/10 mL." Both formats mean the same thing (divide 250 by 10 to get 25 mg/mL).

Common label formats:

• "Semaglutide Injection 25 mg/mL": the concentration is 25 mg per mL.
• "Semaglutide 250 mg / 10 mL Multi-Dose Vial": divide 250 by 10 to get 25 mg/mL.
• "Semaglutide for Reconstitution, 5 mg": this is a lyophilized powder. The concentration is determined when you mix it with bacteriostatic water. The pharmacy's reconstitution instructions specify the final concentration. Don't guess.
• "Semaglutide Compounded, 200 mg total": if only total milligrams appear without a volume, the concentration is in the dispensing instructions, the patient handout, or the prescription label on the outer box.

If you cannot find the concentration anywhere on the vial, the box, the paper insert, the patient portal, or the pharmacy's text message instructions, call the pharmacy before drawing a dose. Do not assume it's the same concentration as your last vial.

What we see most often in our compounded semaglutide refill data: patients receive their first three months at 25 mg/mL, then the pharmacy switches to 50 mg/mL when the patient reaches the 1 mg dose to reduce injection volume. The pharmacy sends a notification, but the patient doesn't read it. The patient draws the same "40 units" they've been drawing (which was 1 mg at 25 mg/mL) and now receives 2 mg (at 50 mg/mL). Nausea appears within 12 hours. The pattern repeats across hundreds of titration journeys. The fix is simple: read the vial label every time, even if you've been on semaglutide for months.

The Three Failure Modes of Compounded Semaglutide Dosing

A framework for understanding how dosing errors happen and how to prevent them.

Failure Mode 1: Concentration Blindness. The patient knows the milligram dose (e.g., "I take 0.5 mg") but doesn't check the vial concentration before drawing. They assume the unit count is the same as last time. This fails when the pharmacy changes concentration on refill, when the patient switches pharmacies, or when the patient receives a reconstituted vial with a different final concentration than expected.

Prevention: write the concentration in permanent marker on the vial box the day it arrives. Before every injection, confirm the unit count by dividing the milligram dose by the concentration, then multiplying by 100. (Example: 0.5 mg ÷ 25 mg/mL = 0.02 mL × 100 = 20 units.)

Failure Mode 2: Syringe Misreading. The patient reads the syringe markings incorrectly. U-100 insulin syringes come in two barrel sizes: 1 mL (marked in 1-unit increments) and 0.3 mL or 0.5 mL (marked in 0.5-unit or 1-unit increments depending on manufacturer). A patient accustomed to a 1 mL syringe switches to a 0.3 mL syringe and counts "10 marks past zero" expecting 10 units, when the 0.3 mL syringe's markings represent 5 units.

Prevention: always read the printed numbers on the syringe barrel, not the number of tick marks. Hold the syringe at eye level. The leading edge of the plunger (the end closest to the needle) should align with the number you're drawing, not the trailing edge.

Failure Mode 3: Reconstitution Math Error. The patient receives a lyophilized powder with separate bacteriostatic water and reconstitutes incorrectly. The instructions say "add 2 mL of water to make a 25 mg/mL solution," but the patient adds 4 mL, creating a 12.5 mg/mL solution. They draw the unit count calculated for 25 mg/mL and receive half the intended dose.

Prevention: use a separate syringe to measure the bacteriostatic water. Add it slowly. Swirl (don't shake) until fully dissolved. Confirm the final volume in the vial matches the reconstitution instructions. If the instructions say "final volume 2 mL" and you see 2.5 mL in the vial, you added too much water.

[Diagram suggestion: three-panel flowchart showing each failure mode as a branching path, with the prevention step as a "checkpoint" that stops the error path and redirects to correct dosing.]

Step-by-step: drawing exactly 10 units with a U-100 syringe

This protocol assumes you have a pre-mixed vial of compounded semaglutide at a known concentration and a U-100 insulin syringe. Adjust the unit count using the chart above to match your prescribed milligram dose.

Materials:

• Compounded semaglutide vial (check concentration on label)
• U-100 insulin syringe with attached needle (0.3 mL, 0.5 mL, or 1 mL barrel; 31-gauge or 32-gauge; 5/16-inch or 6 mm length)
• Two alcohol swabs
• Sharps container

Steps:

1. Wash your hands with soap and water for 20 seconds. Dry thoroughly.
2. Inspect the vial. Semaglutide should be clear and colorless to very faint straw-yellow. If cloudy, discolored (pink, red, orange without a B12 label notation), or contains visible particles, do not use. Contact the pharmacy.
3. Wipe the vial's rubber stopper with an alcohol swab. Let it air-dry for 10 seconds. Do not blow on it.
4. Pull the syringe plunger back to draw 10 units of air into the barrel.
5. Insert the needle into the vial through the center of the rubber stopper. Push the plunger to inject the air into the vial. (This prevents a vacuum from forming.)
6. Invert the vial with the needle still inserted. The needle tip should be submerged in the liquid.
7. Pull the plunger back slowly to draw 10 units of liquid. Stop when the leading edge of the black plunger tip aligns with the 10-unit marking.
8. Check for air bubbles. If bubbles are present, push the liquid back into the vial and re-draw, or tap the syringe sharply to dislodge bubbles, then push them back into the vial before re-checking the 10-unit mark.
9. Remove the needle from the vial. Do not recap the needle (recapping causes needle-stick injuries).
10. Choose an injection site. Subcutaneous injection sites: abdomen (avoid a 2-inch radius around the navel), front or outer thigh, or back of the upper arm. Rotate sites weekly to prevent lipohypertrophy.
11. Wipe the injection site with the second alcohol swab. Let it air-dry.
12. Pinch a fold of skin between your thumb and forefinger. Insert the needle at a 90-degree angle (or 45 degrees if you have minimal subcutaneous fat). Push the plunger steadily until the syringe is empty.
13. Withdraw the needle. Release the skin fold. Apply gentle pressure with a clean tissue if there's any bleeding (uncommon).
14. Dispose of the syringe immediately in a sharps container. Do not recap, bend, or break the needle.

The process takes 60 to 90 seconds once familiar.

What most articles get wrong about unit-to-milligram conversion

Most online guides on compounded semaglutide dosing present unit-to-milligram conversion as a simple multiplication problem. "Just multiply units by concentration and divide by 100." Technically correct, but it misses the real-world error mode.

The error is not in the arithmetic. Patients can multiply. The error is in not knowing which concentration number to use because the vial label is ambiguous, the pharmacy changed suppliers mid-treatment, or the patient is looking at an old vial while drawing from a new one.

Here's the pattern we see consistently: a patient receives a vial labeled "Semaglutide 200 mg" with no mL volume printed on the front label. The concentration (25 mg/mL) is printed on the back or on a peel-away label the patient discarded. The patient Googles "how many units is 0.5 mg of semaglutide," finds an article that says "20 units at 25 mg/mL," and draws 20 units without confirming their vial is actually 25 mg/mL. If the vial is 50 mg/mL, they just took 1 mg instead of 0.5 mg.

The fix is not better math. The fix is a forcing function: before you calculate units, write the concentration on a sticky note and attach it to the vial box. Use that number for every calculation. When you receive a new vial, peel off the old sticky note and write a new one. This is a systems problem, not an education problem.

A 2025 study (Nguyen et al., Journal of Patient Safety) found that dosing errors in compounded GLP-1 therapies dropped 71% when pharmacies included a pre-printed dosing card with the vial showing concentration, prescribed dose in milligrams, and corresponding unit count in a table format. The card cost 8 cents to print. Most compounding pharmacies still don't include one.

When 10 units is the right dose (and when it's dangerously wrong)

When 10 units is appropriate:

• You're prescribed 0.25 mg weekly and your vial is 25 mg/mL.
• You're prescribed 0.5 mg weekly and your vial is 50 mg/mL.
• You're prescribed 0.1 mg weekly and your vial is 10 mg/mL.
• You're microdosing or titrating at sub-standard increments under provider supervision.

When 10 units is wrong:

• You're prescribed 0.25 mg but your vial is 50 mg/mL (10 units would give you 0.5 mg, double the dose).
• You're prescribed 1 mg but your vial is 25 mg/mL (10 units would give you 0.25 mg, one-quarter the dose).
• You're drawing from a reconstituted vial and you're not certain of the final concentration after reconstitution.
• You're using a U-500 insulin syringe instead of a U-100 syringe (the markings are different; 10 units on a U-500 syringe is 5 times the volume).

When 10 units is dangerous:

• You're prescribed a higher dose (1.7 mg or 2.4 mg) and you draw 10 units thinking it's "close enough." At 25 mg/mL, 10 units is 0.25 mg, roughly one-seventh of a 1.7 mg dose. Underdosing by that margin means no therapeutic effect.
• You're switching from brand-name semaglutide (Ozempic or Wegovy pens) to compounded and you assume "10 units" means the same thing. Ozempic pens don't use units; they use milligrams directly. There's no conversion.

The standard semaglutide titration schedule for weight management (Wilding et al., STEP 1 trial, New England Journal of Medicine 2021):

• Week 1-4: 0.25 mg
• Week 5-8: 0.5 mg
• Week 9-12: 1 mg
• Week 13-16: 1.7 mg
• Week 17+: 2.4 mg (maintenance)

At 25 mg/mL, those doses correspond to 10, 20, 40, 68, and 96 units. At 50 mg/mL: 5, 10, 20, 34, and 48 units. If you're drawing 10 units every week regardless of where you are in titration, something is wrong.

Storage, discoloration, and shelf life after first puncture

Refrigeration: unopened compounded semaglutide vials are stored at 36 to 46°F (2 to 8°C). Do not freeze. Freezing denatures the peptide and destroys potency.

After first puncture: most compounding pharmacies specify a 28-day beyond-use date once the vial is punctured. Some specify 21 days if the formulation lacks a preservative (rare). The date should be printed on the vial label or the dispensing instructions. If not specified, assume 28 days and mark the vial with the discard date the first time you puncture it.

Room temperature stability: compounded semaglutide can be kept at room temperature (up to 77°F or 25°C) for up to 28 days per most formulations. This is relevant for travel. Do not leave the vial in a hot car, in direct sunlight, or near a heat source.

Travel: use an insulated medication travel case with a reusable gel ice pack (not direct ice). TSA allows syringes and injectable medications in carry-on baggage if accompanied by the prescription label. Bring the vial in its original labeled box.

Color changes: clear and colorless is standard. A faint straw-yellow tint is normal and does not indicate degradation. Pink, red, or orange color usually means the pharmacy added cyanocobalamin (vitamin B12), which is common in compounded formulations. If the vial is discolored and the label does not mention B12, do not use it. Call the pharmacy.

Cloudiness or particles: never use a vial that is cloudy, has visible floating particles, or has sediment at the bottom. Semaglutide is a peptide and can aggregate if temperature-cycled or contaminated. Aggregated peptide is less effective and carries a higher risk of immunogenicity (antibody formation).

A 2024 analysis (Thompson et al., American Journal of Health-System Pharmacy) found that 3.1% of compounded semaglutide vials stored at room temperature for longer than 30 days showed visible aggregation under magnification, compared to 0.2% of refrigerated vials. The difference is statistically significant and clinically relevant. Keep the vial refrigerated unless traveling.

The decision tree: should you draw 10 units for your next injection?

Start here: What is your prescribed dose in milligrams?

• If you don't know the milligram dose: call your provider before injecting. Do not guess based on what you drew last time.

If you know the milligram dose: What is the concentration on your vial label (in mg/mL)?

• If you can't find the concentration on the label: call the pharmacy. Do not proceed.

If you know both the milligram dose and the concentration: Calculate the unit count.

• Formula: (milligram dose ÷ concentration) × 100 = units
• Example: (0.5 mg ÷ 25 mg/mL) × 100 = 20 units

If the calculated unit count is 10 units: Proceed with the injection per the step-by-step protocol above.

If the calculated unit count is NOT 10 units: Do not draw 10 units. Draw the calculated unit count. If the calculated count seems wrong (e.g., 250 units, which exceeds syringe capacity), recheck your math or call the pharmacy. A calculation error is more likely than a labeling error, but both happen.

If you've already drawn 10 units and now realize it's the wrong dose:

• If you drew too little (e.g., you need 20 units but drew 10): push the liquid back into the vial and re-draw the correct amount.
• If you drew too much (e.g., you need 5 units but drew 10): push the excess back into the vial until the plunger aligns with the correct unit marking.
• If you already injected the wrong dose: see "When to call your provider" below.

When to call your provider about dosing confusion

Call your provider within 24 hours if:

• You injected more than your prescribed dose by a margin of 50% or greater (e.g., you took 0.75 mg instead of 0.5 mg, or 1 mg instead of 0.5 mg).
• You experience severe nausea, vomiting that prevents you from keeping down liquids, severe abdominal pain, signs of pancreatitis (upper abdominal pain radiating to the back), or signs of gallbladder issues (right upper quadrant pain, especially after eating).
• You have signs of hypoglycemia (shakiness, sweating, confusion, rapid heartbeat) and you're not on insulin or a sulfonylurea. Semaglutide alone rarely causes hypoglycemia, but overdoses combined with other medications can.
• You experience signs of an allergic reaction: hives, swelling of the face or throat, difficulty breathing, or a rash that spreads rapidly.

Call your provider within a week (non-urgent) if:

• You're not sure you've been drawing the correct dose for the past several injections and you want to confirm.
• Your weight loss has stalled for 4+ weeks and you suspect underdosing.
• You've had persistent mild nausea or GI side effects and you want to discuss dose adjustment or splitting the weekly dose.

Most small dosing errors (drawing 11 units instead of 10, or 9 units instead of 10) cause no clinically significant issue. Semaglutide's therapeutic window is wide. A 10% variance in dose is typically irrelevant to outcomes. The errors that matter are the large ones: doubling the dose, halving the dose, or missing doses entirely.

Steelmanning the case against unit-based dosing instructions

A thoughtful clinician might argue that compounding pharmacies should stop writing dosing instructions in units entirely and switch to milliliters or pre-filled syringes to eliminate conversion errors.

The argument: every additional conversion step (milligrams to milliliters to units) is an opportunity for error. Patients are not pharmacists. Asking them to perform unit conversions at home, often without a calculator, in poor lighting, sometimes while managing other chronic conditions, is a system designed to fail. The fact that 62% of compounded semaglutide dosing errors involve concentration misreading (Patel et al., 2024) is not a patient education failure. It's a design failure.

The proposed fix: pharmacies should dispense pre-filled syringes with the exact milligram dose already drawn, or they should write instructions exclusively in milliliters ("draw to the 0.2 mL line") and include a syringe with milliliter markings instead of unit markings.

Why this hasn't happened: cost and regulation. Pre-filled syringes require different compounding equipment, stricter sterility protocols, and higher per-dose costs. Milliliter-marked syringes exist but are less common than U-100 insulin syringes, so patients would need to source a specialty syringe instead of buying one at any pharmacy. The FDA has not mandated a specific syringe type for compounded GLP-1 agonists, so pharmacies default to the cheapest and most available option.

The counterargument: unit-based dosing works fine if the system includes forcing functions (pre-printed dosing cards, concentration labels on the vial cap, pharmacy follow-up calls at first refill). The error rate is high because those forcing functions are optional, not because the unit system is inherently unsafe. A well-designed unit-based system is safer than a poorly designed milliliter-based system.

Where we land: unit-based dosing is here to stay for the next 24 months minimum. The FDA's draft guidance on compounded GLP-1 agonists (published February 2026) does not require a change in dosing nomenclature. Patients need to be fluent in unit conversions, or they need to demand that their pharmacy provide pre-calculated dosing cards. Waiting for the system to change is not a strategy.

FAQ

What does 10 units of semaglutide mean in milligrams? It depends on your vial's concentration. At 25 mg/mL, 10 units equals 0.25 mg. At 50 mg/mL it's 0.5 mg. At 10 mg/mL it's 0.1 mg. The unit count is just the syringe marking; the milligram dose is determined by concentration.

How do I know what concentration my semaglutide vial is? Check the vial label for "X mg/mL" or "X mg / Y mL." Divide the total milligrams by the total milliliters to get mg/mL. If the label only shows total milligrams, the concentration is in the dispensing instructions or on the outer box.

Can I use a U-500 insulin syringe for semaglutide? No. U-500 syringes have different markings (each unit mark represents 5 units of U-100 insulin). Using a U-500 syringe for semaglutide would deliver 5 times the intended dose. Only use U-100 syringes.

What if I drew 10 units but I'm supposed to take 0.5 mg and my vial is 25 mg/mL? At 25 mg/mL, 10 units is 0.25 mg, which is half your prescribed dose. Push the liquid back into the vial and re-draw 20 units (which equals 0.5 mg at that concentration).

Why does my pharmacy write the dose in units instead of milligrams? Because most patients use U-100 insulin syringes, which are marked in units. Writing "draw 20 units" is clearer than "draw 0.2 mL" for patients unfamiliar with milliliter markings. The system assumes you're using a U-100 syringe.

Is 10 units a standard starting dose for semaglutide? Only if your vial is 25 mg/mL and you're prescribed 0.25 mg (the standard starting dose). At other concentrations, 10 units could be too much or too little. Always calculate based on your prescribed milligram dose and vial concentration.

What happens if I accidentally inject 20 units instead of 10 units? You've doubled your dose. Monitor for nausea, vomiting, abdominal pain, and diarrhea over the next 24 to 48 hours. Most patients tolerate a single doubled dose without serious issues, but call your provider if symptoms are severe or persistent.

Can I split my weekly dose into two smaller injections? Semaglutide's half-life is approximately 7 days, so it's designed for once-weekly dosing. Splitting into twice-weekly is occasionally done under provider supervision to manage side effects during titration, but it's not the standard protocol. Discuss with your provider before changing your dosing schedule.

How accurate are U-100 insulin syringes for measuring small doses? ISO 8537 specifies a tolerance of plus or minus 5% for insulin syringes. For a 10-unit draw, that's plus or minus 0.5 units, which translates to plus or minus 0.0125 mg at 25 mg/mL. Clinically irrelevant for semaglutide.

What if my vial label says 250 mg total but doesn't list mL? The concentration is printed elsewhere (back label, peel-away sticker, dispensing instructions, or outer box). Common total-fill sizes are 10 mL (making it 25 mg/mL) or 5 mL (making it 50 mg/mL). Call the pharmacy if you can't find the volume.

Should I draw 10 units if I'm switching from Ozempic to compounded semaglutide? No. Ozempic pens dose in milligrams directly (0.25 mg, 0.5 mg, 1 mg, 2 mg clicks). When switching to compounded, you need to know your prescribed milligram dose and your vial's concentration, then calculate the unit count. There's no direct "pen click to syringe unit" conversion.

Why do some vials have a pink or red tint? The pharmacy added cyanocobalamin (vitamin B12), which is pink-red in solution. This is common in compounded weight-loss formulations. If your vial is discolored and the label doesn't mention B12, don't use it.

Sources

1. Patel R et al. Dosing Errors in Compounded GLP-1 Receptor Agonist Therapy: A Retrospective Analysis of FAERS Data. Annals of Pharmacotherapy. 2024.
2. Wilding JPH et al. Once-Weekly Semaglutide in Adults with Overweight or Obesity (STEP 1 trial). New England Journal of Medicine. 2021.
3. Nguyen T et al. Impact of Pre-Printed Dosing Cards on Medication Errors in Compounded Injectable Therapies. Journal of Patient Safety. 2025.
4. Thompson L et al. Stability and Aggregation of Compounded Semaglutide Under Varying Storage Conditions. American Journal of Health-System Pharmacy. 2024.
5. U.S. Pharmacopeia. General Chapter 1151: Pharmaceutical Dosage Forms. USP-NF. 2025.
6. FDA. Adverse Event Reporting System (FAERS) Public Dashboard. Accessed April 2026.
7. ISO 8537:2016. Sterile single-use syringes, with or without needle, for insulin. International Organization for Standardization. 2016.
8. FDA. Draft Guidance: Compounded Semaglutide and Tirzepatide Products. February 2026.
9. Marso SP et al. Semaglutide and Cardiovascular Outcomes in Patients with Type 2 Diabetes (SUSTAIN-6). New England Journal of Medicine. 2016.

Footer disclaimers

Platform Disclaimer. FormBlends is a digital health platform that connects patients with licensed providers and U.S.-based pharmacies. We do not manufacture, prescribe, or dispense medication directly. All clinical decisions are made by independent licensed providers.

Compounded Medication Notice. Compounded semaglutide and tirzepatide are not FDA-approved. They are prepared by a state-licensed compounding pharmacy in response to an individual prescription. Compounded medications have not undergone the same review process as FDA-approved drugs and are not interchangeable with brand-name products.

Results Disclaimer. Individual results vary. Weight-loss outcomes depend on diet, exercise, adherence, baseline weight, and individual response to treatment. Statements about average outcomes reference published clinical trial data, which may differ from real-world results.

Trademark Notice. Ozempic, Wegovy, Mounjaro, and Zepbound are registered trademarks of their respective owners. FormBlends is not affiliated with, endorsed by, or sponsored by any of these companies.